Both in Pharmaceuticals

Ovid Therapeutics vs Capricor Therapeutics

Over the past year OVID returned +81.4% and CAPR returned +15.7%; their daily moves had a correlation of 0.10.

OVID +81.4% CAPR +15.7%Growth of $1, one year, split-adjusted
MetricOVIDCAPR
Price$2.54$8.57
Market cap$496.1M$498.3M
Today+3.25%−1.61%
1 month−9.3%−10.6%
6 months+20.4%−69.1%
Year to date+55.8%−70.3%
1 year+46.8%—
Revenue growth (YoY)−88.3%—
Gross margin100.0%—
Net margin−2047.6%—
P/E (TTM)——
Price / sales313.4×—
Net cash$117.2M$237.9M
Dividend yield——
Volatility (60d)51.8%265.6%
Short % of float13.4%48.0%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

OVID vs CAPR: Ovid Therapeutics vs Capricor Therapeutics Stock Comparison | Gainbot